The Federal Competition and Consumer Protection Commission (FCCPC), has launched an inquiry into the high cost of drugs and price disparities across Nigeria.
The Inquiry, which began on Wednesday in Abuja, is titled “Inquiry into the High Cost and Variation of Drug Prices in the Pharmaceutical and Healthcare Sector.”
The session, attended by Nairametrics, later featured a technical discussion that brought together key stakeholders, including the Association of Community Pharmacists of Nigeria (ACPN), the Pharmaceutical Society of Nigeria (PSN), and the National Health Insurance Authority (NHIA).